金钗石斛治疗糖尿病心肌病的研究进展-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

金钗石斛治疗糖尿病心肌病的研究进展

Therapeutic mechanisms and advances of dendrobium nobile in diabetic cardiomyopathy: A comprehensive review

ES评分 0 浏览量：58 下载量：0

DOI	10.12208/j.ijcr.20250188
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2025, 9(4)
作者	李宏伟¹,李继舟¹,李雅甜¹,张晔²,杨红玲²*,
作者单位	1 大理大学临床医学院云南大理,2 云南省第三人民医院云南昆明
摘要	糖尿病心肌病（Diabetic Cardiomyopathy, DCM）是糖尿病常见的并发症之一，以心肌代谢紊乱、纤维化、氧化应激和线粒体功能障碍为特征。近年来，天然药物金钗石斛（Dendrobium nobile）因其多糖和生物碱成分的潜在药理作用受到广泛关注。本文结合近年研究，综述金钗石斛在糖尿病心肌病治疗中的机制及应用进展。通过分析金钗石斛多糖在调节脂质代谢、抗心肌细胞凋亡、抑制炎症反应、抗氧化应激等方面的药理作用，指出其在DCM治疗中的潜力和未来研究方向。
Abstract	Diabetic cardiomyopathy(DCM), a significant complication of diabetes mellitus, is characterized by myocardial metabolic disturbances, fibrosis, oxidative stress, and mitochondrial dysfunction. In recent years, Dendrobium nobile(DN), a natural medicinal herb, has garnered significant attention for its pharmacological potential attributed to bioactive components such as polysaccharides and alkaloids. This review synthesizes current research progress on the mechanisms and therapeutic applications of DN in DCM management. Specifically, DN polysaccharides(DNP)exhibit multifaceted cardioprotective effects, including ameliorating lipid metabolism dysregulation, suppressing inflammatory cascades, mitigating oxidative damage, and restoring mitochondrial bioenergetics. Additionally, DN-derived alkaloids contributeto glycemic control and myocardial remodeling inhibition. By integrating experimental evidence from preclinical studies, this article highlights recent advances in understanding DNs molecular targets and itstranslational prospects for combating DCM pathogenesis.
关键词	金钗石斛多糖；糖尿病心肌病；治疗
KeyWord	Dendrobium nobile polysaccharides; Diabetic cardiomyopathy; Treatment
基金项目
页码	66-69

参考文献
相关文献

[1] GBD 2021 Diabetes Collaborators. “Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.” Lancet (London, England) vol. 402,10397 (2023): 203-234.
[2] Xu, Yu et al. “Diabetes in China part 1: epidemiology and risk factors.” The Lancet. Public health vol. 9,12 (2024): e1089-e1097.
[3] Tan, Yi et al. “Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.” Nature reviews. Cardiology vol. 17,9 (2020): 585-607.
[4] Meng, Linlin et al. “NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways.” Science advances vol. 9,31 (2023): eadd4222.
[5] Ritchie, Rebecca H, and E Dale Abel. “Basic Mechanisms of Diabetic Heart Disease.” Circulation research vol. 126,11 (2020): 1501-1525.
[6] Cho, So Yeon et al. “Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer's model mice.” Translational psychiatry vol. 14,1 34. 18 Jan. 2024.
[7] Gorgojo-Martínez, Juan J et al. “Clinical Recommendations for Managing Genitourinary Adverse Effects in Patients Treated with SGLT-2 Inhibitors: A Multidisciplinary Expert Consensus.” Journal of clinical medicine vol. 13,21 6509. 30 Oct. 2024.
[8] Avagimyan A, Popov S, Shalnova S. The Pathophysiological Basis of Diabetic Cardiomyopathy Development. Curr Probl Cardiol. 2022;47(9):101156.
[9] Ho KL, Karwi QG, Connolly D, et al. Metabolic, structural and biochemical changes in diabetes and the development of heart failure. Diabetologia. 2022;65(3):411-423.
[10] Cai W, Chong K, Huang Y, Huang C, Yin L. Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress. Redox Biol. 2024;69:103010.
[11] Ramesh P, Yeo JL, Brady EM, McCann GP. Role of inflammation in diabetic cardiomyopathy. Ther Adv Endocrinol Metab. 2022;13:20420188221083530. Published 2022 Mar 15.
[12] Lee SA, Cozzi M, Bush EL, Rabb H. Distant Organ Dysfunction in Acute Kidney Injury: A Review. Am J Kidney Dis. 2018;72(6):846-856.
[13] Li J, Xie Y, Zheng S, et al. Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy. Biomed Pharmacother. 2024;175:116790.
[14] Song Z, Wang J, Zhang L. Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy. Int J Med Sci. 2024;21(4):612-622. Published 2024 Jan 21.
[15] Fan, C., Sun, X., Wang, X., & Yu, H. (2023). Therapeutic potential of the chemical composition of Dendrobium nobile Lindl. Frontiers in Pharmacology , 14, 1163830.
[16] 张静,韩伟,杨长福,等.金钗石斛化学成分和药理作用研究进展与质量标志物（Q-Marker）预测分析
[J].药物评价研究,2024,47(08):1914-1928.
[17] 刘莹莹,武俊紫,李伟,等.金钗石斛多糖对2型糖尿病大鼠心肌组织凋亡相关蛋白的影响
[J].中西医结合心脑血管病杂志,2018,16(18):2621-2626.
[18] 李继舟,李宏伟,汤胜宇,等.金钗石斛多糖调节Plin5介导心肌细胞脂肪酸β氧化改善糖尿病大鼠心肌损伤
[J].昆明医科大学学报,2024,45(10):8-16.
[19] 刘莹莹,武俊紫,李伟,等.金钗石斛多糖对2型糖尿病大鼠心肌组织中RIP蛋白表达影响
[J].辽宁中医药大学学报, 2017, 19(12):44-48.
[20] 刘莹莹,武俊紫,李伟,等.金钗石斛多糖对Ⅱ型糖尿病大鼠心肌组织中MMP-1和MMP-9表达的影响
[J].西部医学,2017,29(10):1346-1351.
[21] 李曼曼,张百霞,何帅兵,等.基于“中药作用机理辅助解析系统”的金钗石斛降糖作用机制研究
[J].中国中药杂志, 2015, 40(19):3709-3712.

引用本文

李宏伟,李继舟,李雅甜,张晔,杨红玲*. 金钗石斛治疗糖尿病心肌病的研究进展 [J]. 国际临床研究杂志. 2025; 9; (4). 66 - 69.

文献评论

相关学者

相关机构